Most Active Biotech Investors in Los Angeles 2026

6 firms writing Biotech checks in Los Angeles, led by U.S. Venture Partners, Google Ventures, Insight Partners — ranked by verified deal count.

Biotech in Los Angeles accounts for 3 tracked companies with verified cap-table data, 3 of which disclose round sizes totalling $273M. The median disclosed raise is $70M, and the largest is Pelage Pharmaceuticals at $154M, ahead of Bionaut Labs ($70M) and PictorLabs ($49M).

The names that recur most often on these biotech cap tables are ARCH Venture Partners (1 company), Google Ventures (1 company), Main Street Advisors (1 company), Visionary Ventures (1 company), YK Bioventures (1 company), Khosla Ventures (1 company). By latest disclosed round, the market skews Series B (3).

Companies tracked: 3
Disclosed funding total: $273M across 3 companies
Median disclosed raise: $70M
Largest raise: Pelage Pharmaceuticals — $154M
Stage mix: Series B 3
Most recent dated round: 2025-10-01

Best funded Biotech in Los Angeles companies

Pelage Pharmaceuticals — $154M (latest: Series B)
Bionaut Labs — $70M (latest: Series B)
PictorLabs — $49M (latest: Series B)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library